Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | DEFB4A |
| Upstream (Parents) |
|---|
| (<<) S100A7 → DEFB4A |
| (<<) CYP2B7P1///CYP2B6 → DEFB4A |
| (<<) CYP2B6 → DEFB4A |
| (<<) SPRR2B → DEFB4A |
| (<<) DGCR2 → DEFB4A |
| (<<) HLA-DQB2 → DEFB4A |
| (<<) PEX11A → DEFB4A |
| Downstream (Children) |
|---|
| DEFB4A → AMELX (>>) |
| DEFB4A → SPRR1B (>>) |
| DEFB4A → S100A7 (>>) |
| DEFB4A → TNIP3 (>>) |
| DEFB4A → SPRR2B (>>) |
| DEFB4A → MYH3 (>>) |
| DEFB4A → SPRR2C (>>) |
| DEFB4A → CD177 (>>) |
| DEFB4A → DIMT1L (>>) |
| DEFB4A → ZNF571 (>>) |
| DEFB4A → PRAMEF11 (>>) |
| DEFB4A → C7orf16 (>>) |
| DEFB4A → IL1F9 (>>) |
| DEFB4A → TAOK2 (>>) |
